Developer docs
API playgroundTry for free, no card

Search company profiles

Lawson Health Research Institute

Full company profile

uuid0003bdo

Namestring
Lawson Health Research Institute
Legal namestring
Lawson Research Institute
Company typeenum
Private
Founded yearint
1983
Descriptiontext

Lawson Health Research Institute (Lawson) is the research arm of St. Joseph's Health Care London, a hospital-based research institute affiliated with Western University and Fanshawe College and collaborating with London Health Sciences Centre. Founded in 1983 and headquartered in London, Ontario, Canada, Lawson conducts discovery-driven and patient-focused research across six specialty areas: aging, chronic diseases, imaging, mental health, mobility and activity, and surgical specialties. The institute employs 1,001-5,000 staff and operates a portfolio that includes Canada's first Siemens BIOGRAPH One PET/MRI scanner, an on-site fecal microbiota transplantation (FMT) capsule production capability supporting the LUNA-2 Phase II clinical trial in non-small cell lung cancer, and a 3D-printed custom thumb splint program for arthritis patients using remote iPhone-based measurement.

Lawson's core technologies combine capital-intensive imaging infrastructure, clinical-stage biotherapeutics manufacturing, and digital health hardware. Key assets include the BIOGRAPH One PET/MRI (enabled by WSIB and WorkSafe Ontario Fund investment), FMT capsules produced in-house for combination immunotherapy trials, and a custom 3D hand-scanning workflow enabling fabrication of patient-specific splints without in-person visits. Active programs span the LUNA-2 trial with 160 enrolled patients across Canada, an Ambroxol repurposing study for Parkinson's-related dementia, Alzheimer's care research via the Cognitive Clinical Research Group, and remote arthritis care targeting underserved communities including the Arctic. The institute's 2025-2030 Strategic Plan outlines priorities for infrastructure development, talent acquisition, and integration of research into clinical care.

Lawson operates a non-profit, grant-funded business model rather than a commercial sales model. Revenue is sourced from a diversified mix of foundation grants (e.g., Canadian Cancer Society, Weston Family Foundation, Arthritis Society of Canada), government and institutional investment (WSIB, WorkSafe Ontario Fund), academic partnerships (Western University, Fanshawe College), and the parent hospital's operating budget. The institute's outputs — clinical trial results, medical imaging capabilities, and medical devices — are distributed through clinical trial networks, healthcare provider training, regional health system integration, and academic publications rather than commercial channels. Its competitive positioning rests on unique imaging infrastructure, embedded hospital-academic partnerships, and specialized research talent recognized through awards such as the Order of Canada and the Canadian Organization of Medical Physicists Gold Medal.

Short descriptiontext

Lawson Health Research Institute is the research arm of St. Joseph's Health Care London, affiliated with Western University, conducting clinical trials, medical imaging, and biomedical device research across aging, oncology, mental health, and mobility specialties for Canadian patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersLondon, Canada
HQ citystring
London
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, medical imaging technology, clinical trial management, biomedical research, translational health research
Industry4 codes
1Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
CodeHLAGAJAMPrimaryYes
2Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
CodeHLACAPAKPrimaryNo
3Point-of-Care & Decentralized Trial Testing Services
CodeHLAGAEAKPrimaryNo
4Microscopy, Imaging & Flow Cytometry Instruments
CodeHLAGAIAEPrimaryNo
NAICS code4 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical and Diagnostic Laboratories62151
  • Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
  • Services-Health Services8000
Product category
Health Research Institute
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Lawson Health Research Institute is the research arm of St. Joseph's Health Care London, conducting discovery-driven, patient-focused health research across aging, chronic diseases, imaging, mental health, mobility and activity, and surgical specialties. It operates clinical trials (including the LUNA-2 trial using FMT capsules for lung cancer treatment), provides advanced imaging research through Canada's first Siemens BIOGRAPH One PET/MRI, and develops novel medical devices such as 3D-printed custom thumb splints. The institute translates research into patient care improvements through collaborations with Western University, London Health Sciences Centre, and national funding partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 160 lung cancer patients enrolled in Canada's largest FMT clinical trial
+1 more record
Product overview1 text field

Lawson Research Institute operates as a health research institute under St. Joseph's Health Care London, conducting discovery-driven and patient-focused research across multiple specialty areas including aging, chronic diseases, imaging, mental health, mobility and activity, and surgical specialties. The institute's portfolio includes medical imaging technology (Canada's first Siemens BIOGRAPH One PET/MRI scanner), clinical trials such as LUNA-2 using FMT capsules for cancer treatment, and 3D-printed medical devices for remote patient care. Researchers work in partnership with Western University, London Health Sciences Centre, and various funding organizations to translate research into patient care improvements.

Product and service3 records
1Siemens BIOGRAPH One PET/MRI Imaging Service
CategoryMedical imaging research
2LUNA-2 FMT Capsules
33D-Printed Custom Thumb Splints
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leads the LUNA-2 clinical trial involving 160 lung cancer patients across Canada, evaluating safety, immune response, and preliminary efficacy of FMT combined with immunotherapy

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates with Lawson on LUNA-2 clinical trial research alongside Canadian Cancer Trials Group researchers

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Proudly affiliated with Western University. Researchers from Western collaborate on Lawson research projects including arthritis care innovation and animal research review

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Proudly affiliated with Fanshawe College as part of the broader academic and healthcare community

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Large Canadian hospital-affiliated research enterprise focused on translational medicine and advanced imaging, with similar grant-funded structure and multi-specialty clinical trial portfolio.

TypeBroad incumbent
Description

Lawson's primary academic affiliate and co-located research partner; comparable in translational research output but broader in scope, including non-clinical science and education.

TypeDirect peer
Description

Co-located academic hospital research institute in London, Ontario that collaborates with Lawson on the LUNA-2 trial and shares patient populations across oncology, imaging, and surgical specialties.

TypeRegional player
Description

Provincial health system research program with comparable multi-specialty clinical trial operations in Western Canada; comparable structure but operates in a different region than Lawson.

TypeDirect peer
Description

Cancer-focused research institute running large-scale clinical trials and translational research; peer because Lawson competes for similar cancer trial sponsorships and translational grants in Canada.

TypeDirect peer
Description

Canada's largest dedicated cancer research and treatment centre, comparable to Lawson's LUNA-2 program in NSCLC and other oncology trial capabilities.

TypeDirect peer
Description

Quebec-based hospital research institute combining clinical care and academic research across multiple specialties, with comparable headcount and grant-driven funding profile.

TypeDirect peer
Description

Major Canadian hospital-affiliated research institute running multi-specialty clinical trials and translational programs, directly comparable to Lawson in scale, governance, and funding model.

TypeDirect peer
Description

Leads the LUNA-2 trial and coordinates Canada's largest cancer clinical trial network, operating in adjacent space to Lawson as a multi-site clinical trial sponsor.

TypeBroad incumbent
Description

Provincial translational cancer research funder and collaborator running multi-site Ontario trials; comparable in cancer trial oversight and translational research funding.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lawson Health Research Institute

Health Research Institutelawsonresearch.ca

Lawson Health Research Institute is the research arm of St. Joseph's Health Care London, affiliated with Western University, conducting clinical trials, medical imaging, and biomedical device research across aging, oncology, mental health, and mobility specialties for Canadian patients.

What Lawson Health Research Institute does

Lawson Health Research Institute (Lawson) is the research arm of St. Joseph's Health Care London, a hospital-based research institute affiliated with Western University and Fanshawe College and collaborating with London Health Sciences Centre. Founded in 1983 and headquartered in London, Ontario, Canada, Lawson conducts discovery-driven and patient-focused research across six specialty areas: aging, chronic diseases, imaging, mental health, mobility and activity, and surgical specialties. The institute employs 1,001-5,000 staff and operates a portfolio that includes Canada's first Siemens BIOGRAPH One PET/MRI scanner, an on-site fecal microbiota transplantation (FMT) capsule production capability supporting the LUNA-2 Phase II clinical trial in non-small cell lung cancer, and a 3D-printed custom thumb splint program for arthritis patients using remote iPhone-based measurement.

Lawson's core technologies combine capital-intensive imaging infrastructure, clinical-stage biotherapeutics manufacturing, and digital health hardware. Key assets include the BIOGRAPH One PET/MRI (enabled by WSIB and WorkSafe Ontario Fund investment), FMT capsules produced in-house for combination immunotherapy trials, and a custom 3D hand-scanning workflow enabling fabrication of patient-specific splints without in-person visits. Active programs span the LUNA-2 trial with 160 enrolled patients across Canada, an Ambroxol repurposing study for Parkinson's-related dementia, Alzheimer's care research via the Cognitive Clinical Research Group, and remote arthritis care targeting underserved communities including the Arctic. The institute's 2025-2030 Strategic Plan outlines priorities for infrastructure development, talent acquisition, and integration of research into clinical care.

Lawson operates a non-profit, grant-funded business model rather than a commercial sales model. Revenue is sourced from a diversified mix of foundation grants (e.g., Canadian Cancer Society, Weston Family Foundation, Arthritis Society of Canada), government and institutional investment (WSIB, WorkSafe Ontario Fund), academic partnerships (Western University, Fanshawe College), and the parent hospital's operating budget. The institute's outputs — clinical trial results, medical imaging capabilities, and medical devices — are distributed through clinical trial networks, healthcare provider training, regional health system integration, and academic publications rather than commercial channels. Its competitive positioning rests on unique imaging infrastructure, embedded hospital-academic partnerships, and specialized research talent recognized through awards such as the Order of Canada and the Canadian Organization of Medical Physicists Gold Medal.

Lawson Health Research Institute firmographics

Firmographics
Name
Lawson Health Research Institute
Legal name
Lawson Research Institute
Website
https://lawsonresearch.ca
Company type
Private
Founded year
1983
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Lawson Health Research Institute is the research arm of St. Joseph's Health Care London, affiliated with Western University, conducting clinical trials, medical imaging, and biomedical device research across aging, oncology, mental health, and mobility specialties for Canadian patients.
Ownership category
akta.pro rank

Lawson Health Research Institute industry classification

Industry
Product category
Health Research Institute
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (62151), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Health Services (8000)
akta.pro primary industry
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
akta.pro secondary industries
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK), Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)

Keywords

  • Clinical research services
  • Medical imaging technology
  • Clinical trial management
  • Biomedical research
  • Translational health research

Where Lawson Health Research Institute is headquartered

Location

Headquarters

HQ city
London
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Lawson Health Research Institute business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Others

Distribution channels3 records

Marketing channels4 records

Lawson Health Research Institute product offering

Product offering

Core offering

Lawson Health Research Institute is the research arm of St. Joseph's Health Care London, conducting discovery-driven, patient-focused health research across aging, chronic diseases, imaging, mental health, mobility and activity, and surgical specialties. It operates clinical trials (including the LUNA-2 trial using FMT capsules for lung cancer treatment), provides advanced imaging research through Canada's first Siemens BIOGRAPH One PET/MRI, and develops novel medical devices such as 3D-printed custom thumb splints. The institute translates research into patient care improvements through collaborations with Western University, London Health Sciences Centre, and national funding partners.

Product overview

Lawson Research Institute operates as a health research institute under St. Joseph's Health Care London, conducting discovery-driven and patient-focused research across multiple specialty areas including aging, chronic diseases, imaging, mental health, mobility and activity, and surgical specialties. The institute's portfolio includes medical imaging technology (Canada's first Siemens BIOGRAPH One PET/MRI scanner), clinical trials such as LUNA-2 using FMT capsules for cancer treatment, and 3D-printed medical devices for remote patient care. Researchers work in partnership with Western University, London Health Sciences Centre, and various funding organizations to translate research into patient care improvements.

Differentiator

Problem solved

Functional benefit

Products and services

  • Siemens BIOGRAPH One PET/MRI Imaging Service
  • LUNA-2 FMT Capsules
  • 3D-Printed Custom Thumb Splints

Quantifiable outcome

  • 160 lung cancer patients enrolled in Canada's largest FMT clinical trial
  • +1 more outcomes

Companies that use Lawson Health Research Institute

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles4 records

Lawson Health Research Institute technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Lawson Health Research Institute partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Canadian Cancer Trials Group (CCTG)coreStrategic or Co-development PartnerLeads the LUNA-2 clinical trial involving 160 lung cancer patients across Canada, evaluating safety, immune response, and preliminary efficacy of FMT combined with immunotherapy
  • London Health Sciences Centre Research InstitutecoreStrategic or Co-development PartnerCollaborates with Lawson on LUNA-2 clinical trial research alongside Canadian Cancer Trials Group researchers
  • Western UniversitycoreStrategic or Co-development PartnerProudly affiliated with Western University. Researchers from Western collaborate on Lawson research projects including arthritis care innovation and animal research review
  • Fanshawe CollegeminorStrategic or Co-development PartnerProudly affiliated with Fanshawe College as part of the broader academic and healthcare community

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Lawson Health Research Institute competitors and assessment

Company assessment

Direct peers

  • Toronto General Hospital Research Institute (UHN): Large Canadian hospital-affiliated research enterprise focused on translational medicine and advanced imaging, with similar grant-funded structure and multi-specialty clinical trial portfolio.
  • London Health Sciences Centre Research Institute: Co-located academic hospital research institute in London, Ontario that collaborates with Lawson on the LUNA-2 trial and shares patient populations across oncology, imaging, and surgical specialties.
  • BC Cancer Research Centre: Cancer-focused research institute running large-scale clinical trials and translational research; peer because Lawson competes for similar cancer trial sponsorships and translational grants in Canada.
  • Princess Margaret Cancer Centre (Research Institute): Canada's largest dedicated cancer research and treatment centre, comparable to Lawson's LUNA-2 program in NSCLC and other oncology trial capabilities.
  • McGill University Health Centre Research Institute: Quebec-based hospital research institute combining clinical care and academic research across multiple specialties, with comparable headcount and grant-driven funding profile.
  • Ottawa Hospital Research Institute: Major Canadian hospital-affiliated research institute running multi-specialty clinical trials and translational programs, directly comparable to Lawson in scale, governance, and funding model.
  • Canadian Cancer Trials Group (CCTG): Leads the LUNA-2 trial and coordinates Canada's largest cancer clinical trial network, operating in adjacent space to Lawson as a multi-site clinical trial sponsor.

Broad incumbents

Regional players

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Lawson Health Research Institute social profiles

Digital presence

Lawson Health Research Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lawson Health Research Institute leadership team

Management profile

Number of profiles

Profiles6 records

Lawson Health Research Institute funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lawson Health Research Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lawson Health Research Institute

What does Lawson Health Research Institute do?

Lawson Health Research Institute is the research arm of St. Joseph's Health Care London, conducting discovery-driven, patient-focused health research across aging, chronic diseases, imaging, mental health, mobility and activity, and surgical specialties. It operates clinical trials (including the LUNA-2 trial using FMT capsules for lung cancer treatment), provides advanced imaging research through Canada's first Siemens BIOGRAPH One PET/MRI, and develops novel medical devices such as 3D-printed custom thumb splints. The institute translates research into patient care improvements through collaborations with Western University, London Health Sciences Centre, and national funding partners.

Is Lawson Health Research Institute a public or private company?

Lawson Health Research Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Lawson Health Research Institute founded?

Lawson Health Research Institute was founded in 1983. It employs 1,001 to 5,000 people.

Where is Lawson Health Research Institute based?

Lawson Health Research Institute is headquartered in London, Canada, in the North America region.

Who are Lawson Health Research Institute's main competitors?

Direct peers on record are Toronto General Hospital Research Institute (UHN), London Health Sciences Centre Research Institute, BC Cancer Research Centre, Princess Margaret Cancer Centre (Research Institute), McGill University Health Centre Research Institute, Ottawa Hospital Research Institute and Canadian Cancer Trials Group (CCTG). Broad incumbents are Western University (Schulich School of Medicine & Dentistry) and Ontario Institute for Cancer Research (OICR). Alberta Health Services - Research, Innovation and Analytics is listed as a regional player.

Does Lawson Health Research Institute have an API?

No public API is recorded for Lawson Health Research Institute.

What industry is Lawson Health Research Institute in?

Lawson Health Research Institute's product category is Health Research Institute. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mirage NewsResearch Reveals Healing Power of Sacred Moments in HealthcareResearch led by Lawson Research Institute and St. Joseph's Health Care London, published in the Journal of General Internal Medicine, has examined how 'sacred moments'—brief experiences of deep connection in healthcare settings—contribute to clinician well-being and reduce burnout.GlobeNewswireUn essai clinique canadien sans précédent évalue des « comprimés de selles » pour améliorer l’immunothérapie du cancer du poumonA new clinical trial called LUNA-2 is evaluating fecal microbiota transplantation (FMT) capsules combined with immunotherapy for non-small cell lung cancer in Canada. Funded by $4 million jointly from the Canadian Cancer Society and the Weston Family Foundation, the phase II trial will enroll 160 patients and represents the largest clinical trial of its kind in Canada. Led by the Canadian Cancer Trials Group with researchers from the London Health Sciences Centre Research Institute and the Lawson Research Institute, the trial aims to improve treatment efficacy and reduce side effects for patients who do not respond to standard immunotherapy.Global NewsNo evidence of ‘secrecy’ over dog testing at London, Ont. hospital: reportAn independent third-party review commissioned by St. Joseph's Health Care London found that dog testing at the hospital's Lawson Research Institute was ethical and met all regulatory standards, with no evidence of intentional secrecy. The review, however, identified gaps in institutional governance, transparency, and communication between the hospital, Lawson, and Western University. The hospital has stopped the research and is developing an action plan to address the recommendations, despite Ontario subsequently banning research testing on dogs and cats.GlobeNewswireRevive Therapeutics Enters into Worldwide Exclusive Agreement with Lawson Health Research Institute to Develop and Commercialize a Novel Long COVID Rapid TestRevive Diagnostics, a subsidiary of Revive Therapeutics, entered a worldwide exclusive license agreement with Lawson Health Research Institute for novel blood biomarkers for long COVID. The company will develop a qELISA test kit and lateral flow device, and evaluate the test as a companion to Bucillamine. No FDA-approved long COVID diagnosis exists, and the test could reduce unnecessary testing and costs.GlobeNewswireQMC Health Inc. Obtains Exclusive Rights to Novel Long COVID Biomarkers in Development of High Sensitivity Long COVID Rapid TestQMC Health announced an agreement with Lawson Health Research Institute for exclusive rights to novel Long COVID biomarkers. The company will use them to develop a point-of-care rapid test via its QDX HPFIS platform. QMC Health is forming a regulatory team and exploring collaborations with U.S. health agencies.PR NewswireCPDC executes its first commercial sublicensing agreement with Lawson Health Research Institute for PSMA-1007, expanding access to the prostate cancer diagnostic agent in OntarioThe Centre for Probe Development and Commercialization (CPDC) has entered into a commercial sublicense agreement with Lawson Health Research Institute to utilize [18F]PSMA-1007 as a diagnostic tool for prostate cancer in London, Ontario. This agreement expands access to the imaging agent and is part of CPDC's ongoing Phase III clinical trial for the diagnosis of recurrent prostate cancer. The collaboration aims to enhance local production and improve treatment outcomes for patients in Ontario.OhaHealth System News Leveraging Virtual Reality to Manage Pain in Paediatric PatientsA study by Lawson Health Research Institute and Children's Hospital at London Health Sciences Centre is investigating the use of virtual reality (VR) to assist pediatric patients during painful procedures involving port access. The research aims to involve 90 pediatric patients, comparing outcomes between VR, tablet technology, and traditional distractions. The study, expected to conclude by the end of the year, may lead to VR becoming a standard clinical tool for managing pain in pediatric patients if proven effective.PR NewswireHigh-dose radiation therapy substantially improves survival in patients once thought to be incurableA phase II randomized clinical trial led by the Lawson Health Research Institute demonstrated that stereotactic ablative radiotherapy (SABR) significantly extends survival for patients with oligometastatic cancer. The study found that adding SABR to standard care increased median overall survival from 28 to 41 months and doubled progression-free survival compared to standard care alone. While the treatment resulted in a higher rate of serious adverse events, researchers concluded that the survival benefits outweigh these risks.GlobeNewswireYabao Pharmaceuticals Announces Exclusive China Partnership With Lawson Health Research InstituteYabao Pharmaceuticals entered an exclusive license with Lawson Health Research Institute to develop annexin A5-based sepsis treatments, completing discovery validation and moving into preclinical development. Yabao holds exclusive rights in China, Taiwan, and Hong Kong, while Lawson retains rights elsewhere; financial terms were not disclosed.GlobeNewswireCanada's Lawson Health Research Institute Investigates Groundbreaking New Technology to Monitor Cerebral Blood Flow in Cardiac Surgery PatientsResearchers at Western University and Lawson Health Research Institute are studying CerOx, a non-invasive device that monitors cerebral blood flow using near-infrared light and ultrasound. The device aims to reduce complications in cardiac surgery, with 11 studies underway and c-FLOW joining in September 2014.